Citarinostat Uses, Dosage, Side Effects and more
Citarinostat is under investigation in clinical trial NCT02886065 (A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM).
| Trade Name | Citarinostat |
| Generic | Citarinostat |
| Citarinostat Other Names | Citarinostat |
| Type | |
| Formula | C24H26ClN5O3 |
| Weight | Average: 467.95 Monoisotopic: 467.1724174 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
